Materials • Major Chemicals
$157.87 ▲ +0.95
(+0.61%)
MKT CAP: $2.72B • VOL: 164.2K
52W L $112 52W H $183
KWR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.89B | $1.84B | $1.95B |
| YoY Revenue Growth % | +2.7% | -5.8% | — |
| Gross Profit | $679.4M | $686.0M | — |
| Gross Margin % | 36.0% | 37.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $53.0M | $194.7M | $214.5M |
| Operating Margin % | 2.8% | 10.6% | 11.0% |
| Net Income (GAAP) | -$2.5M | $116.6M | $112.7M |
| EBITDA (Normalized) | $97.7M | $228.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $136.5M | $204.6M | $279.0M |
| Capital Expenditures (CapEx) | $55.9M | $41.8M | — |
| Free Cash Flow (FCF) | $80.6M | $162.8M | $279.0M |
| FCF Margin % | 4.3% | 8.8% | 14.3% |
| Return on Invested Capital (ROIC %) | 2.1% | 8.4% | — |
| Cash & Short-Term Equivalents | $179.8M | $188.9M | — |
| Total Debt (Short + Long Term) | $834.9M | $669.6M | — |
| Total Stockholders' Equity | $1.37B | $1.35B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR KWR.